The cyberknife market size has grown rapidly in recent years. It will grow from $0.63 billion in 2024 to $0.73 billion in 2025 at a compound annual growth rate (CAGR) of 16.6%. The growth in the historic period can be attributed to rising cancer incidence, growing aging population, demand for precision medicine, patient preference for non-invasive procedures, advancements in radiotherapy.
The cyberknife market size is expected to see rapid growth in the next few years. It will grow to $1.35 billion in 2029 at a compound annual growth rate (CAGR) of 16.6%. The growth in the forecast period can be attributed to increasing cancer burden worldwide, advancements in oncology research, expanding access to healthcare, rising awareness and education, integration with multidisciplinary approaches. Major trends in the forecast period include rise in proton therapy integration, shift towards outpatient and freestanding centers, patient-centric treatment planning, growing clinical evidence and research, telemedicine and remote treatment planning.
The anticipated growth in the cyberknife market is driven by the increasing incidence of cancer, a severe disorder characterized by rapid and uncontrolled cell reproduction leading to abnormal growth. CyberKnife, approved for the treatment of various cancers, presents a non-invasive and pain-free alternative in cases where radiation therapy is recommended. Ongoing research and development efforts aimed at enhancing the CyberKnife system and expanding its applications to address additional medical conditions are expected to contribute to the market's growth. For instance, as reported by ABC News Internet Ventures in January 2022, the projected number of newly diagnosed cancer cases in 2022 is around 2 million, representing a significant increase compared to the 1 million new cases reported in 2021. The escalating incidence of cancer, with approximately 5,250 new cases diagnosed daily in the United States, underscores the driving force behind the growth of the cyberknife market.
The growth of the cyberknife market is further propelled by the increasing preference for non-invasive or minimally invasive procedures. Minimally invasive interventions involve medical procedures that cause minimal disruption to the body's normal structures. CyberKnife, as a robotic radiosurgery system, offers several advantages in minimally invasive procedures, including precise tumor targeting, adaptability to moving targets, a reduced number of treatment sessions, enhanced patient comfort, and more. According to The American Society of Plastic Surgeons (ASPS) data in September 2023, approximately 23.7 million cosmetic minimally invasive procedures were performed in 2022. Specifically, the number of minimally invasive procedures involving Neuromodulator Injections surged by 73% from 2019, reaching approximately 8,736,591 procedures in 2022. This substantial growth in minimally invasive procedures highlights the increasing preference for such approaches and their contribution to the growth of the cyberknife market.
Key players in the CyberKnife market are concentrating on developing innovative solutions, including medical training programs, to enhance treatment precision, improve patient outcomes, and broaden the range of conditions that can be treated while reducing side effects associated with traditional radiation therapies. Medical training programs are structured educational initiatives designed to improve the skills and knowledge of healthcare professionals, focusing on specific medical technologies, treatments, and best practices to enhance patient care. For instance, in September 2024, Accuray Incorporated, a U.S.-based manufacturer of radiation therapy systems, launched medical professional training for the CyberKnife S7 System at its education center. This facility serves as a comprehensive training hub aimed at equipping medical professionals involved in radiosurgery and radiotherapy with tailored training programs and hands-on experience with the CyberKnife and Radixact systems.
Major players in the cyberknife market are directing their efforts towards the development of online adaptive therapy solutions. Online adaptive therapy involves a dynamic and real-time approach to treatment planning and delivery in radiation therapy. For instance, in October 2023, Accuray Incorporated introduced 'Cenos,' an online adaptive therapy option specifically designed for the Radixact System. Cenos empowers medical care teams to swiftly and effectively modify a treatment plan if necessary while the patient is still on the treatment table. Its integration enables Accuray customers to conduct online adaptation of treatment plans, accommodating changes that may arise between treatment sessions.
In September 2022, Standard Imaging, a US-based provider of quality assurance solutions in radiation therapy, acquired Integrated Medical Technologies (IMT) to enhance its offerings and market reach. This acquisition aims to better serve IMT's customer base by integrating complementary solutions, expanding production capabilities, and broadening market segments, particularly in tissue-equivalent dosimetry phantoms. Integrated Medical Technologies (IMT), a US-based company specializing in radiation therapy and medical imaging phantoms for both radiotherapy and diagnostic applications, aligns with Standard Imaging's objectives to provide comprehensive solutions in the radiation therapy domain.
Major companies operating in the cyberknife market include Accuray Incorporated, Elekta AB, Medtronic plc, Varian Medical Systems Inc., Brainlab AG, Ion Beam Applications S.A., Mevion Medical Systems Inc., Zap Surgical Systems Inc., Xcision Medical Systems LLC, ViewRay Inc., Hitachi Ltd., Mitsubishi Electric Corporation, Best Theratronics Ltd., Siemens Healthineers AG, Toshiba Medical Systems Corporation, Orfit Industries NV, Technicare Medical Systems Inc., ProTom International Inc., Advanced Accelerator Applications S.A., Theragenics Corporation, IntraOp Medical Corporation, CIVCO Radiotherapy, IsoRay Medical Inc., RaySearch Laboratories AB, RefleXion Medical Inc., Shinva Medical Instrument Co. Ltd., Klarity Medical Products, MIM Software Inc., Elekta Instrument AB, Nordion Inc.
North America was the largest region in the cyberknife market in 2024. The regions covered in the cyberknife market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cyberknife market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The CyberKnife System offers a non-invasive treatment solution for both malignant and non-cancerous tumors, as well as other medical conditions necessitating radiation therapy. This innovative system is designed to enable smaller treatment margins around tumors, thereby minimizing exposure to high radiation doses for healthy tissues.
The primary categorizations of the CyberKnife system include linear accelerator-based and standalone CyberKnife models. Linear accelerator-based CyberKnife refers to a system incorporating a linear accelerator (linac) directly onto a robotic platform for the delivery of high-energy photons or X-rays essential for radiation therapy. This specific type of CyberKnife device utilizing a linear accelerator is employed to administer precise and high-energy X-rays or photons for radiation therapy applications. CyberKnife systems find extensive use in healthcare settings such as hospitals, clinics, ambulatory surgical centers, and radiotherapy facilities. They serve as integral tools for treating tumors, cancer, vascular malformations, and various other medical conditions, providing a sophisticated and non-invasive approach to radiation therapy.
The cyberknife market research report is one of a series of new reports that provides cyberknife market statistics, including cyberknife industry global market size, regional shares, competitors with a cyberknife market share, detailed cyberknife market segments, market trends, and opportunities, and any further data you may need to thrive in the cyberknife industry. This cyberknife market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The cyberknife market consists of sales of robotic linac, robotic manipulator, image guidance system, image tracking system. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The cyberknife market size is expected to see rapid growth in the next few years. It will grow to $1.35 billion in 2029 at a compound annual growth rate (CAGR) of 16.6%. The growth in the forecast period can be attributed to increasing cancer burden worldwide, advancements in oncology research, expanding access to healthcare, rising awareness and education, integration with multidisciplinary approaches. Major trends in the forecast period include rise in proton therapy integration, shift towards outpatient and freestanding centers, patient-centric treatment planning, growing clinical evidence and research, telemedicine and remote treatment planning.
The anticipated growth in the cyberknife market is driven by the increasing incidence of cancer, a severe disorder characterized by rapid and uncontrolled cell reproduction leading to abnormal growth. CyberKnife, approved for the treatment of various cancers, presents a non-invasive and pain-free alternative in cases where radiation therapy is recommended. Ongoing research and development efforts aimed at enhancing the CyberKnife system and expanding its applications to address additional medical conditions are expected to contribute to the market's growth. For instance, as reported by ABC News Internet Ventures in January 2022, the projected number of newly diagnosed cancer cases in 2022 is around 2 million, representing a significant increase compared to the 1 million new cases reported in 2021. The escalating incidence of cancer, with approximately 5,250 new cases diagnosed daily in the United States, underscores the driving force behind the growth of the cyberknife market.
The growth of the cyberknife market is further propelled by the increasing preference for non-invasive or minimally invasive procedures. Minimally invasive interventions involve medical procedures that cause minimal disruption to the body's normal structures. CyberKnife, as a robotic radiosurgery system, offers several advantages in minimally invasive procedures, including precise tumor targeting, adaptability to moving targets, a reduced number of treatment sessions, enhanced patient comfort, and more. According to The American Society of Plastic Surgeons (ASPS) data in September 2023, approximately 23.7 million cosmetic minimally invasive procedures were performed in 2022. Specifically, the number of minimally invasive procedures involving Neuromodulator Injections surged by 73% from 2019, reaching approximately 8,736,591 procedures in 2022. This substantial growth in minimally invasive procedures highlights the increasing preference for such approaches and their contribution to the growth of the cyberknife market.
Key players in the CyberKnife market are concentrating on developing innovative solutions, including medical training programs, to enhance treatment precision, improve patient outcomes, and broaden the range of conditions that can be treated while reducing side effects associated with traditional radiation therapies. Medical training programs are structured educational initiatives designed to improve the skills and knowledge of healthcare professionals, focusing on specific medical technologies, treatments, and best practices to enhance patient care. For instance, in September 2024, Accuray Incorporated, a U.S.-based manufacturer of radiation therapy systems, launched medical professional training for the CyberKnife S7 System at its education center. This facility serves as a comprehensive training hub aimed at equipping medical professionals involved in radiosurgery and radiotherapy with tailored training programs and hands-on experience with the CyberKnife and Radixact systems.
Major players in the cyberknife market are directing their efforts towards the development of online adaptive therapy solutions. Online adaptive therapy involves a dynamic and real-time approach to treatment planning and delivery in radiation therapy. For instance, in October 2023, Accuray Incorporated introduced 'Cenos,' an online adaptive therapy option specifically designed for the Radixact System. Cenos empowers medical care teams to swiftly and effectively modify a treatment plan if necessary while the patient is still on the treatment table. Its integration enables Accuray customers to conduct online adaptation of treatment plans, accommodating changes that may arise between treatment sessions.
In September 2022, Standard Imaging, a US-based provider of quality assurance solutions in radiation therapy, acquired Integrated Medical Technologies (IMT) to enhance its offerings and market reach. This acquisition aims to better serve IMT's customer base by integrating complementary solutions, expanding production capabilities, and broadening market segments, particularly in tissue-equivalent dosimetry phantoms. Integrated Medical Technologies (IMT), a US-based company specializing in radiation therapy and medical imaging phantoms for both radiotherapy and diagnostic applications, aligns with Standard Imaging's objectives to provide comprehensive solutions in the radiation therapy domain.
Major companies operating in the cyberknife market include Accuray Incorporated, Elekta AB, Medtronic plc, Varian Medical Systems Inc., Brainlab AG, Ion Beam Applications S.A., Mevion Medical Systems Inc., Zap Surgical Systems Inc., Xcision Medical Systems LLC, ViewRay Inc., Hitachi Ltd., Mitsubishi Electric Corporation, Best Theratronics Ltd., Siemens Healthineers AG, Toshiba Medical Systems Corporation, Orfit Industries NV, Technicare Medical Systems Inc., ProTom International Inc., Advanced Accelerator Applications S.A., Theragenics Corporation, IntraOp Medical Corporation, CIVCO Radiotherapy, IsoRay Medical Inc., RaySearch Laboratories AB, RefleXion Medical Inc., Shinva Medical Instrument Co. Ltd., Klarity Medical Products, MIM Software Inc., Elekta Instrument AB, Nordion Inc.
North America was the largest region in the cyberknife market in 2024. The regions covered in the cyberknife market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cyberknife market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The CyberKnife System offers a non-invasive treatment solution for both malignant and non-cancerous tumors, as well as other medical conditions necessitating radiation therapy. This innovative system is designed to enable smaller treatment margins around tumors, thereby minimizing exposure to high radiation doses for healthy tissues.
The primary categorizations of the CyberKnife system include linear accelerator-based and standalone CyberKnife models. Linear accelerator-based CyberKnife refers to a system incorporating a linear accelerator (linac) directly onto a robotic platform for the delivery of high-energy photons or X-rays essential for radiation therapy. This specific type of CyberKnife device utilizing a linear accelerator is employed to administer precise and high-energy X-rays or photons for radiation therapy applications. CyberKnife systems find extensive use in healthcare settings such as hospitals, clinics, ambulatory surgical centers, and radiotherapy facilities. They serve as integral tools for treating tumors, cancer, vascular malformations, and various other medical conditions, providing a sophisticated and non-invasive approach to radiation therapy.
The cyberknife market research report is one of a series of new reports that provides cyberknife market statistics, including cyberknife industry global market size, regional shares, competitors with a cyberknife market share, detailed cyberknife market segments, market trends, and opportunities, and any further data you may need to thrive in the cyberknife industry. This cyberknife market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The cyberknife market consists of sales of robotic linac, robotic manipulator, image guidance system, image tracking system. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Cyberknife Market Characteristics3. Cyberknife Market Trends and Strategies4. Cyberknife Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid and Recovery on the Market32. Global Cyberknife Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Cyberknife Market34. Recent Developments in the Cyberknife Market
5. Global Cyberknife Growth Analysis and Strategic Analysis Framework
6. Cyberknife Market Segmentation
7. Cyberknife Market Regional and Country Analysis
8. Asia-Pacific Cyberknife Market
9. China Cyberknife Market
10. India Cyberknife Market
11. Japan Cyberknife Market
12. Australia Cyberknife Market
13. Indonesia Cyberknife Market
14. South Korea Cyberknife Market
15. Western Europe Cyberknife Market
16. UK Cyberknife Market
17. Germany Cyberknife Market
18. France Cyberknife Market
19. Italy Cyberknife Market
20. Spain Cyberknife Market
21. Eastern Europe Cyberknife Market
22. Russia Cyberknife Market
23. North America Cyberknife Market
24. USA Cyberknife Market
25. Canada Cyberknife Market
26. South America Cyberknife Market
27. Brazil Cyberknife Market
28. Middle East Cyberknife Market
29. Africa Cyberknife Market
30. Cyberknife Market Competitive Landscape and Company Profiles
31. Cyberknife Market Other Major and Innovative Companies
35. Cyberknife Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Cyberknife Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on cyberknife market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for cyberknife? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cyberknife market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Type: Linear Accelerator-Based; Standalone Cyberknife2) By Application: Tumor; Cancer; Vascular malformation; Other Applications
3) By End-User: Hospitals; Clinics; Ambulatory Surgical Center; Radiotherapy Centers; Other End Users
Subsegments:
1) By Linear Accelerator-Based: Conventional Linear Accelerators; Advanced Linear Accelerators; Integrated Linear Accelerators2) By Standalone Cyberknife: Fixed Cyberknife Systems; Mobile Cyberknife Systems; Upgraded Cyberknife Systems
Key Companies Mentioned: Accuray Incorporated; Elekta AB; Medtronic plc; Varian Medical Systems Inc.; Brainlab AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Accuray Incorporated
- Elekta AB
- Medtronic plc
- Varian Medical Systems Inc.
- Brainlab AG
- Ion Beam Applications S.A.
- Mevion Medical Systems Inc.
- Zap Surgical Systems Inc.
- Xcision Medical Systems LLC
- ViewRay Inc.
- Hitachi Ltd.
- Mitsubishi Electric Corporation
- Best Theratronics Ltd.
- Siemens Healthineers AG
- Toshiba Medical Systems Corporation
- Orfit Industries NV
- Technicare Medical Systems Inc.
- ProTom International Inc.
- Advanced Accelerator Applications S.A.
- Theragenics Corporation
- IntraOp Medical Corporation
- CIVCO Radiotherapy
- IsoRay Medical Inc.
- RaySearch Laboratories AB
- RefleXion Medical Inc.
- Shinva Medical Instrument Co. Ltd.
- Klarity Medical Products
- MIM Software Inc.
- Elekta Instrument AB
- Nordion Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | February 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 0.73 Billion |
| Forecasted Market Value ( USD | $ 1.35 Billion |
| Compound Annual Growth Rate | 16.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 30 |
